Target intelligence / Profile preview

Flavivirus envelope protein fusion loop (E-FL) (E-FL)

Target
E-FL
Molecular classification
Viral fusion protein, Class II viral fusion protein, Envelope glycoprotein
01

Overview

The Flavivirus envelope (E) protein fusion loop is a highly conserved, hydrophobic peptide sequence located at the tip of domain II (DII) of the viral E protein (Rey et al., 1995, Nature). It is essential for the infection process of various flaviviruses, including Dengue, Zika, and West Nile viruses, by mediating the fusion between the viral envelope and the host endosomal membrane (Pierson & Kielian, 2013, Virology). Upon exposure to the acidic environment of the endosome, the E protein undergoes a structural transition from a metastable dimer to a stable trimer, which projects the fusion loop toward the host membrane for insertion (Stiasny et al., 2006, J Virol). Due to its high degree of sequence conservation across the Flavivirus genus, the fusion loop is a major target for broadly neutralizing antibodies (bnAbs) and potential small-molecule fusion inhibitors. However, a significant challenge in targeting this site is the risk of antibody-dependent enhancement (ADE), where non-neutralizing or sub-neutralizing antibodies against the fusion loop can promote viral uptake into myeloid cells via Fc receptors (Dejnirattisai et al., 2010, Science). This phenomenon can lead to increased viral load and more severe clinical manifestations, such as Dengue Hemorrhagic Fever. Consequently, therapeutic strategies must focus on achieving high-affinity binding or engineering antibody Fc regions to minimize ADE risks. The fusion loop remains a focal point for structure-based vaccine design aiming to elicit protective, rather than sensitizing, immune responses.

Other names
E-DII fusion loopFlavivirus fusion peptidecd loop of domain IIConserved fusion loop (CFL)
02

Mechanism of action

Neutralization of viral infectivity by blocking the insertion of the fusion loop into the host endosomal membrane or preventing the E protein conformational change required for fusion.

03

Biological functions

Viral entryMembrane fusionEndosomal escapeHost cell attachment
04

Disease associations

InfectionDengue feverZika virus diseaseWest Nile feverYellow feverJapanese encephalitis
05

Safety considerations

Antibody-dependent enhancement (ADE)Viral escape mutantsLow neutralization potency against specific viral strains
06

Interacting drugs

4G2 (monoclonal antibody)

3 more in the full profile.

07

Biomarkers

Neutralizing antibody titer (PRNT)Viral RNA load (RT-qPCR)E-protein specific IgG/IgM levelsNS1 antigenemia

Beyond the preview

Go deeper on Flavivirus envelope protein fusion loop (E-FL) (E-FL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flavivirus envelope protein fusion loop (E-FL) (E-FL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call